Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell–mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach

Phosphoinositide 3-kinases (PI3Ks) are among the most frequently activated signaling pathways in cancer. In chronic lymphocytic leukemia (CLL), signals from the microenvironment are critical for expansion of the malignant B cells, and cause constitutive activation of PI3Ks. CXCR4 is a key receptor f...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Blood
Auteurs principaux: Niedermeier, Matthias, Hennessy, Bryan T., Knight, Zachary A., Henneberg, Marina, Hu, Jianhua, Kurtova, Antonina V., Wierda, William G., Keating, Michael J., Shokat, Kevan M., Burger, Jan A.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2009
Sujets:
Lymphoid Neoplasia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4580965/
https://ncbi.nlm.nih.gov/pubmed/19318683
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2008-06-165068
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires